Karrar O, Abdelmagid M, Rana M, Iftikhar M, et al. Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival. Am J Hematol 2023 Dec 15. doi: 10.1002/ajh.27180.
PMID: 38100217